Weill Cornell Medicine – Immunotherapy Program

The Meyer Cancer Center at Weill Cornell integrates high-level academic research with clinical application, focusing heavily on “next-gen” immunotherapy agents. Their programs are particularly strong in genitourinary and breast cancer immunotherapies, where they utilize bispecific antibodies—unique molecules that act as a bridge, physically pulling immune cells into direct contact with cancer cells.